Although the Company continues to intersect copper-gold-silver mineralization that is consistent with carbonate replacement ( ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
This NDA submission is an important milestone, and it brings gedatolisib one step closer to becoming available for patients with HR+/HER2- advanced breast cancer,” said Brian Sullivan, CEO and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback